For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Precigen Inc (NASDAQ: PGEN) closed at $1.38 in the last session, up 3.76% from day before closing price of $1.33. In other words, the price has increased by $3.76 from its previous closing price. On the day, 0.89 million shares were traded. PGEN stock price reached its highest trading level at $1.39 during the session, while it also had its lowest trading level at $1.32.
Ratios:
We take a closer look at PGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 28 ’23 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28 ’23. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22 ’23, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 343508224 and an Enterprise Value of 287750368. For the stock, the TTM Price-to-Sale (P/S) ratio is 55.23 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 46.225 whereas that against EBITDA is -3.498.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.75, which has changed by 0.22123897 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -5.34%, while the 200-Day Moving Average is calculated to be 2.45%.
Shares Statistics:
According to the various share statistics, PGEN traded on average about 1.02M shares per day over the past 3-months and 909900 shares per day over the past 10 days. A total of 248.92M shares are outstanding, with a floating share count of 122.70M. Insiders hold about 50.71% of the company’s shares, while institutions hold 30.79% stake in the company. Shares short for PGEN as of 1711584000 were 16901197 with a Short Ratio of 16.49, compared to 1709164800 on 17270995. Therefore, it implies a Short% of Shares Outstanding of 16901197 and a Short% of Float of 11.44.
